| 000 | 01530 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514002446.0 | ||
| 264 | 0 | _c20010802 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.49.1.91 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLund, J N | |
| 245 | 0 | 0 |
_aRisks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. _h[electronic resource] |
| 260 |
_bGut _cJul 2001 |
||
| 300 |
_a91-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdenoma _xdiagnosis |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aColonoscopy _xmethods |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xeconomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPoisson Distribution |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSigmoidoscopy _xmethods |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aScholefield, J H | |
| 700 | 1 | _aGrainge, M J | |
| 700 | 1 | _aSmith, S J | |
| 700 | 1 | _aMangham, C | |
| 700 | 1 | _aArmitage, N C | |
| 700 | 1 | _aRobinson, M H | |
| 700 | 1 | _aLogan, R F | |
| 773 | 0 |
_tGut _gvol. 49 _gno. 1 _gp. 91-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.49.1.91 _zAvailable from publisher's website |
| 999 |
_c11343085 _d11343085 |
||